- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07557875
Healing Efficacy of Diode Laser in Lingual Frenectomy
Evaluation of the Healing Efficacy of Diode Laser in Lingual Frenectomy
This study aims to compare the wound healing efficacy and postoperative experiences between the 940 nm diode laser technique and the traditional electrosurgery method for treating ankyloglossia (tongue-tie) in children aged 3 to 6 years.
Participants are randomly assigned to one of two groups: Experimental Group - Patients undergo lingual frenectomy using a 940 nm diode laser and Active Comparator Group - Patients undergo the procedure using conventional high-frequency electrosurgery.
The study evaluates several key outcomes at multiple intervals (24 hours, 3 days, 1 week, and 1 month post-surgery), including: (1) Wound Healing: Measured by the Early Wound Healing Score (EHS); (2) Pain Levels: Assessed using the Wong-Baker FACES Pain Rating Scale; (3) Bleeding Control: Evaluation of intraoperative bleeding; (4) Tongue Mobility: Measurement of free tongue length according to Kotlow's classification.
The goal is to determine if the diode laser provides superior healing, less pain, and better bleeding control compared to electrosurgery.
Study Overview
Status
Conditions
Detailed Description
Participant Allocation: Participants meeting the inclusion criteria (aged 3-6, diagnosed with Kotlow grade 3 or 4 ankyloglossia) are randomly assigned to one of two groups using a simple randomization method (drawing lots):
- Group 1 (Laser Group): Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase) with a power of 1W (average) and 2W (peak) in pulsed mode (CP2).
- Group 2 (Electrosurgery Group): Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C) in continuous contact mode.
Surgical Procedure: Both groups follow a standardized surgical protocol:
- Anesthesia: Local anesthesia with 2% Lidocaine/Adrenaline (0.45 ml).
- Technique: Transverse incision without suturing or muscle dissection to release the lingual frenum.
- Safety Measures: Use of protective eyewear for the laser group and electrode grounding pads for the electrosurgery group.
Data Collection and Blinding:
- Blinding: This is a single-blind study where the participants and their guardians are unaware of the assigned treatment group. The evaluator measuring post-operative outcomes is also blinded to the surgical method used.
Follow-up Schedule: Evaluations are conducted at five specific intervals:
- Baseline (T0): Pre-operative measurements.
- Post-operative: At 24 hours (T1), 3 days (T2), 1 week (T3), and 1 month (T4).
Evaluation Criteria:
- Wound Healing: Assessed by the Early Wound Healing Score (EHS), focusing on re-epithelialization (CSR), haemostasis (CSH), and inflammation (CSI).
- Pain Intensity: Self-reported by patients using the Wong-Baker FACES Pain Rating Scale.
- Tongue Function: Measuring the increase in free tongue length (mm) using a Quick Tongue-Tie (QTT) tool.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Phong Dai Lam, PhD, DDS
- Phone Number: (+84) 906312958
- Email: phonglam@ump.edu.vn
Study Locations
-
-
-
Ho Chi Minh City, Vietnam
- Recruiting
- Children's Hospital 1, Department of Odonto-Stomatology
-
Contact:
- Phung Van Ho, DDS
- Phone Number: (+84) 983791484
- Email: hvphung.ckii.rhm23@ump.edu.vn
-
Principal Investigator:
- Phung Van Ho, DDS
-
Sub-Investigator:
- Phong Dai Lam, PhD, DDS
-
Ho Chi Minh City, Vietnam
- Recruiting
- Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
-
Contact:
- Phong Dai Lam, PhD, DDS
- Phone Number: (+84) 906312958
- Email: phonglam@ump.edu.vn
-
Sub-Investigator:
- Phung Van Ho, DDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged between 3 and 6 years.
- Diagnosed with grade 3 or grade 4 ankyloglossia according to Kotlow's classification (1999).
- Parents or legal guardians provide informed consent for the child to participate in the study.
- Patients and guardians agree to follow the follow-up schedule (24 hours, 3 days, 1 week, and 1 month post-surgery).
Exclusion Criteria:
- History of allergy to local anesthetics (e.g., Lidocaine, Adrenaline).
- Patients with systemic diseases or high-risk surgical factors (e.g., cardiovascular disease, bleeding disorders, hemophilia, epilepsy, or uncontrolled asthma).
- Uncooperative patients who are unable to undergo the procedure under local anesthesia or fail to follow post-operative instructions.
- Patients who withdraw from the study before completion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Diode Laser Group
Patients in this group undergo lingual frenectomy using a 940 nm diode laser (Epic X, Biolase).
The procedure is performed using a transverse incision technique without suturing.
Laser settings include an average power of 1W, peak power of 2W in pulsed mode (CP2), and a 940 nm wavelength.
|
Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase).
The laser is set to pulsed mode (CP2), average power 1W, and peak power 2W.
The procedure involves a transverse incision to release the frenum without suturing.
Protective eyewear is mandatory for the patient and surgical team.
Other Names:
|
|
Active Comparator: Electrosurgery Group
Patients in this group undergo lingual frenectomy using a high-frequency electrosurgical unit (ERBE-VIO 100C).
The procedure follows the same transverse incision protocol without suturing as the experimental group.
|
Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C).
The procedure follows a standardized transverse incision protocol without suturing.
A grounding pad (electrode) is applied to the patient's body to complete the circuit.
This serves as the active comparator representing the conventional surgical method at the hospital.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early Wound Healing Score (EHS)
Time Frame: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
The EHS is used to evaluate the early healing of periodontal soft tissue wounds.
It is the sum of three components: Clinical Signs of Re-epithelialization (CSR), Clinical Signs of Haemostasis (CSH), and Clinical Signs of Inflammation (CSI).
The total score ranges from 0 to 10, where a higher score indicates better and faster wound healing (10 being perfect healing).
|
24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity assessed by Wong-Baker FACES Pain Rating Scale
Time Frame: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
Patients self-assess their pain levels using a scale of 6 faces representing different pain intensities.
Scores range from 0 (no pain) to 10 (worst possible pain), with increments of 2 (0, 2, 4, 6, 8, 10).
|
24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
|
Level of Intraoperative Bleeding
Time Frame: During the surgical procedure (T0)
|
Bleeding is assessed during the surgical procedure and categorized into 2 levels: Grade 1 (No bleeding) and Grade 2 (Bleeding present, requiring local haemostatic measures like gauze pressure or laser/electrosurgery coagulation).
|
During the surgical procedure (T0)
|
|
Increase in Free Tongue Length
Time Frame: Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.
|
Measured as the distance (in mm) from the attachment of the lingual frenum on the ventral surface of the tongue to the tip of the tongue using a Quick Tongue-Tie (QTT) measurement tool.
|
Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Kotlow LA. Ankyloglossia (tongue-tie): a diagnostic and treatment quandary. Quintessence Int. 1999 Apr;30(4):259-62.
- Hwang WB, Kim DJ, Oh GS, Park JH. Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation. Immune Netw. 2018 Oct 23;18(5):e35. doi: 10.4110/in.2018.18.e35. eCollection 2018 Oct.
- Mazzoni A, Navarro RS, Fernandes KPS, Mesquita-Ferrari RA, Horliana ACRT, Silva T, Santos EM, Sobral APT, Junior AB, Nammour S, Motta LJ, Bussadori SK. Comparison of the Effects of High-Power Diode Laser and Electrocautery for Lingual Frenectomy in Infants: A Blinded Randomized Controlled Clinical Trial. J Clin Med. 2022 Jun 30;11(13):3783. doi: 10.3390/jcm11133783.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Stomatognathic Diseases
- Wounds and Injuries
- Postoperative Complications
- Pathologic Processes
- Body Temperature Changes
- Heat Stress Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Hyperthermia
- Ankyloglossia
- Pain, Postoperative
- Equipment and Supplies
- Lasers
- Optical Devices
- Radiation Equipment and Supplies
- Lasers, Semiconductor
Other Study ID Numbers
- IRB00010293-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankyloglossia
-
University of AlbertaEnrolling by invitation
-
United States Naval Medical Center, PortsmouthCompleted
-
Georgetown UniversityRecruitingBreastfeeding Support | AnkyloglossiaUnited States
-
The Oregon ClinicCompletedBreastfeeding | Ankyloglossia
-
Hanoi Medical UniversityCompleted
-
Yonsei UniversityCompleted
-
The Oregon ClinicCompletedBreastfeeding | Ankyloglossia
-
Parc de Salut MarNot yet recruiting
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Erasme University HospitalUniversité Libre de Bruxelles; King Baudouin Foundation; Fonds Erasme pour la...Active, not recruitingBreastfeeding | Breastfeeding Outcomes | Ankyloglossia | Breastfeeding Duration | Breastfeeding Self-EfficacyBelgium
Clinical Trials on Lingual Frenectomy using 940nm Diode Laser
-
Marmara UniversityCompleted
-
Kocaeli UniversityCompletedFrenulum; Hypertrophy, LipTurkey (Türkiye)
-
Nourhan M.AlyCompleted
-
University of BaghdadCompleted
-
Trakya UniversityCompletedFrenulum; Hypertrophy
-
Mahmoud SalemRecruiting
-
Sohag UniversityEnrolling by invitation
-
Mennatullah osama ahmed zaki wahbaCompleted
-
Ariel UniversityCompletedLaser Hysteroscopic Ablation of Submucous MyomaSpain, Italy, Israel
-
Marmara UniversityCompletedFrenulum; Hypertrophy, Lip